Hugo Petit Appointed CFO of OxThera
Stockholm – 7 September 2018 – OxThera AB, a Stockholm-based privately-held rare disease company today announced the appointment of Hugo Petit as its new Chief Financial Officer. Mr Petit previously served as the Chief Financial Officer of MedCap AB. While at MedCap, Hugo led the company’s listing on Nasdaq Stockholm. Prior to joining MedCap, Hugo held several roles as Chief Financial Officer in small as well as medium sized companies. Earlier in his career, Hugo also spent several years as consultant at McKinsey & Company in Stockholm. “It is my pleasure to welcome Hugo as CFO of